Results 121 to 130 of about 10,915 (160)

[Long noncoding RNA HClnc1 promotes proliferation and migration of liver cancer cells by targeting RBBP5/KAT2B complex to enhance ODC1 transcription]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Feng Z, Li W, Zhang M, Wang P, Shuai Y, Zhang H.   +5 more
europepmc   +1 more source

[PreS1 Antigen of HBV Down-Regulates MHC-Ⅰ on the Surface of Hepatocytes and Promotes Hepatocarcinogenesis]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban, 2022
Rao JJ, Zeng F, Ji MS, Xu X, Yu CF, Yang J, Liu L, Liu ZX.   +7 more
europepmc   +1 more source

[Utilizing Sonodynamic Therapy-Induced Pyroptosis for Liver Cancer Therapy]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Zhang N, Dai Z.
europepmc   +1 more source

[Fucoidan-Modified Phase-Transitional Contrast Agent for Ultrasound Imaging and Targeting of Hepatoma Cells]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban, 2022
Huang JB, Yang L, Yang R, Yan F, Peng YL, Xu JS.   +5 more
europepmc   +1 more source

SREBPs及其在肝细胞癌中的作用机制研究进展

Zhongguo shiyan zhenduanxue
肝细胞癌（hepatocellular carcinoma, HCC）在全球原发性肝癌中占比超过80%,给健康带来沉重的负担，被认为是全球癌症相关死亡的第四大常见原因[1]。肝癌病例数量的不断增加不仅与人口老龄化相关，在过去20年中，与肥胖相关的脂肪性肝病的逐渐增加也加剧了肝癌病例总数的增长。值得注意的是，快速上升的非酒精性脂肪性肝病（nonalcoholic fatty liver disease, NAFLD ...
陈雨恒, 吕凌
doaj  

[Impact of nonsteroidal anti-inflammatory drugs on efficacy of anti-PD-1 therapy for primary liver cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Li R, Huang C, Hong C, Wang J, Li Q, Hu C, Cui H, Dong Z, Zhu H, Liu L, Xiao L.   +10 more
europepmc   +1 more source

[Biejiajian Pill Regulates Ferroptosis in Hepatocellular Carcinoma Cells via p62/Keap1/NRF2 Signaling Pathway: A Mechanism Study]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Chen W, He C, Wen B, Sun H, Yang X, Chen W, Liu Y, Zhong B, He S.   +8 more
europepmc   +1 more source

[The TGF‑β/miR-23a-3p/IRF1 axis mediates immune escape of hepatocellular carcinoma by inhibiting major histocompatibility complex class I]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yu Y, Tu L, Liu Y, Song X, Shao Q, Tang X.   +5 more
europepmc   +1 more source

[Serum LAPTM4B-35 protein as a novel diagnostic marker for hepatocellular carcinoma]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2021
Pang Y, Zhang S, Yang H, Zhou RL.
europepmc   +1 more source

[TRIM21 suppresses invasion of hepatocellular carcinoma cells by promoting β-catenin ubiquitylation and degradation]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Zhang Z, Zhu Z, Sheng H, Sun J, Cao C.
europepmc   +1 more source